Association between concomitant use of direct oral anticoagulants and statins and major bleeding in patients with non-valvular atrial fibrillation

被引:0
|
作者
de Burgos Gonzalez, Airam [1 ]
Soriano, Lucia Cea [2 ]
Huerta, Consuelo [3 ]
机构
[1] Agencia Espanola Med & Prod Sanitarios AEMPS, Madrid, Spain
[2] Univ Complutense Madrid, Fac Med, Dept Publ Hlth & Child Hlth, Madrid, Spain
[3] Univ Complutense Madrid, Fac Med, Dept Publ Hlth, Madrid, Spain
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
614
引用
收藏
页码:278 / 278
页数:1
相关论文
共 50 条
  • [21] Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation
    Manuel Cappellari
    Monica Carletti
    Alessandra Danese
    Paolo Bovi
    [J]. Journal of Thrombosis and Thrombolysis, 2016, 42 : 393 - 398
  • [22] ASSOCIATION BETWEEN THE RISK OF MAJOR BLEEDING AND CONCOMITANT USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS WITH ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION
    Rahman, A.
    Platt, R.
    Beradid, S.
    Boivin, J. F.
    Rej, S.
    Renoux, C.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 113 - 113
  • [23] Impact of renal function on bleeding risk in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: Subanalysis of the DIRECT registry
    Hirata, A.
    Sotomi, Y.
    Kobayashi, T.
    Amiya, R.
    Hirayama, A.
    Higuchi, Y.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2957 - 2957
  • [24] Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants
    Beshir, S. A.
    Aziz, Z.
    Yap, L. B.
    Chee, K. H.
    Lo, Y. L.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (02) : 209 - 219
  • [25] Association between direct-acting oral anticoagulants vs. warfarin with the risk of osteoporosis in patients with non-valvular atrial fibrillation
    Akhtar, Tauseef
    Hajra, Adrija
    Bhyan, Poonam
    Ghosh, Raktim K.
    Bandyopadhyay, Dhrubajyoti
    Aronow, Wilbert S.
    [J]. IJC HEART & VASCULATURE, 2020, 27
  • [26] New anticoagulants in patients with non-valvular atrial fibrillation
    Zellerhoff, S.
    Lewalter, T.
    Eckardt, L.
    Treszl, A.
    Wegscheider, K.
    Breithardt, G.
    [J]. NERVENHEILKUNDE, 2012, 31 (11) : 813 - 820
  • [27] Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients
    Campos-Staffico, Alessandra M. M.
    Dorsch, Michael P. P.
    Barnes, Geoffrey D. D.
    Zhu, Hao-Jie
    Limdi, Nita A. A.
    Luzum, Jasmine A. A.
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation
    Destephan, C.
    Waller, A. H.
    Patel, R. J.
    Dhruvakumar, S.
    Mazza, V.
    Gerula, C.
    Maher, J.
    Kaluski, E.
    [J]. MINERVA CARDIOANGIOLOGICA, 2012, 60 (04): : 425 - 431
  • [29] ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON)
    Derosa, Giuseppe
    Rizzo, Manfredi
    Brunetti, Natale Daniele
    Raddino, Riccardo
    Gavazzoni, Mara
    Pasini, Gianfranco
    Gaudio, Giovanni
    Maggi, Antonio
    D'Angelo, Angela
    De Gennaro, Luisa
    Maffioli, Pamela
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (08)
  • [30] New oral anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation
    Bosch, Montserrat
    Llop, Roser
    Lalueza, Pilar
    del Mar Villar, Maria
    [J]. MEDICINA CLINICA, 2013, 140 (05): : 229 - 231